Healthcare / Drug Discovery
Synthetic biology (SB) is an emerging discipline, which is slowly reorienting the field of drug discovery. It focuses on re-engineering bacteria and yeast for use as microscopic drug factories, and in the manipulation of mammalian gene expression. Synthetic biology designs biological devices (synthetic cells or cell-free system) to trigger a biological response with respect to input controlled signal. In Drug Discovery, such devices would be used to activate gene expression of biosynthetic units to explore natural products -like chemical space. Genome editing tools give the possibility of following through reporter genes the action of a particular output signal, which is very useful to validate drug target or disease models as well as merging constraints from both Drug Discovery and drug production.
- Synthetic Cells
- Peptide Nanoparticle-Based Vaccines
- Liposome-Based Synthetic Vaccines
- Reverse Vaccines against Microbial Pathogens
Related Conference of Healthcare / Drug Discovery
September 24-25, 2026
19th World Congress on Advances in Stem Cell Research and Regenerative Medicine
Paris, France
November 16-17, 2026
19th International Conference on Human Genomics and Genomic Medicine
Tokyo, Japan

